News
Endo Inc. approved more than $3.5 million in retention bonuses for key executives, and that figure could grow, as it works to ...
2d
VISTA.Today on MSNMalvern-Based Endo Approves $3.5M in Retention Bonuses for Executives Ahead of MergerMalvern-based Endo has approved $3.5 million in retention bonuses for its key executives as it works toward a merger with ...
Mallinckrodt and Malvern, Pennsylvania-based Endo's predecessor company ... Upon completion of the merger, Olafsson will become CEO of the combined company, and Paul Efron, a member of the ...
Per deal terms, Endo shareholders will receive Mallinckrodt stock and a share of $80 million in cash. After the merger, a business made up of Endo’s sterile injectables and both companies ...
Two companies forced to file for bankruptcy protection due to opioid litigation in the US – Mallinckrodt and Endo – have agreed to join forces via a $6.7 billion merger. According to the ...
(Reuters) -Mallinckrodt and Endo are exploring a potential merger that could be valued at about $7 billion, person familiar with the matter told Reuters on Wednesday. A deal could likely be ...
Wilmington, Delaware--(Newsfile Corp. - March 13, 2025) - Rigrodsky Law, P.A. is investigating Endo, Inc. ("Endo") (OTC: NDOI) regarding possible breaches of fiduciary duties and other violations ...
"That helps us." Endo shareholders will get $80 million in cash and own 49.9% of the combined company, while Mallinckrodt shareholders will own the rest for an enterprise value of $6.7 billion, the ...
Mallinckrodt, Endo Merger To Create Pharma Entity Valued At $7 Billion Mallinckrodt and Endo are merging in a $6.7 billion deal, with a pro forma NYSE listing and $900 million in financing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results